Global Nano-drug Market Research Report 2021
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Research Predicts that Nano-drug Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global Nano-drug Market Overview:
Global Nano-drug Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Nano-drug involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Impact of COVID-19 on Nano-drug Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Nano-drug market in 2020.
Global Nano-drug Market Segmentation
By Type, Nano-drug market has been segmented into:
Liposomes
Polymeric Micelles
Solid lipid Nanoparticles
Microemulsion and Nanoemulsion
Nanosuspension
By Application, Nano-drug market has been segmented into:
Cancer and Tumors
Autoimmune Disorders
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in Nano-drug market are:
Merck
Pfizer
Novartis
Abbott
GlaxoSmithKline
Roche
Sanofi
Eli Lilly
Astrazeneca
Johnson & Johnson
Celgene
Novavax
Stryker
Gilead Sciences
OSI Pharmaceuticals
Kadmon Pharmaceuticals
Samyang Biopharm
Mitsubishi Pharma
Kaken Pharmaceutical
Selecta Biosciences
Par Pharmaceutical
Cerulean Pharma
Navidea Biopharmaceuticals
Lummy
1. Market Overview of Nano-drug
1.1 Nano-drug Market Overview
1.1.1 Nano-drug Product Scope
1.1.2 Market Status and Outlook
1.2 Nano-drug Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Nano-drug Historic Market Size by Regions (2015-2020)
1.4 Nano-drug Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Nano-drug Sales Market by Type (2015-2026)
2.1 Global Nano-drug Historic Market Size by Type (2015-2020)
2.2 Global Nano-drug Forecasted Market Size by Type (2021-2026)
2.3 Liposomes
2.4 Polymeric Micelles
2.5 Solid lipid Nanoparticles
2.6 Microemulsion and Nanoemulsion
2.7 Nanosuspension
3. Covid-19 Impact Nano-drug Sales Market by Application (2015-2026)
3.1 Global Nano-drug Historic Market Size by Application (2015-2020)
3.2 Global Nano-drug Forecasted Market Size by Application (2021-2026)
3.3 Cancer and Tumors
3.4 Autoimmune Disorders
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Nano-drug Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Nano-drug Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Nano-drug Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Nano-drug Business
5.1 Merck
5.1.1 Merck Company Profile
5.1.2 Merck Nano-drug Product Specification
5.1.3 Merck Nano-drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 Pfizer
5.2.1 Pfizer Company Profile
5.2.2 Pfizer Nano-drug Product Specification
5.2.3 Pfizer Nano-drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 Novartis
5.3.1 Novartis Company Profile
5.3.2 Novartis Nano-drug Product Specification
5.3.3 Novartis Nano-drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 Abbott
5.4.1 Abbott Company Profile
5.4.2 Abbott Nano-drug Product Specification
5.4.3 Abbott Nano-drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 GlaxoSmithKline
5.5.1 GlaxoSmithKline Company Profile
5.5.2 GlaxoSmithKline Nano-drug Product Specification
5.5.3 GlaxoSmithKline Nano-drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 Roche
5.6.1 Roche Company Profile
5.6.2 Roche Nano-drug Product Specification
5.6.3 Roche Nano-drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 Sanofi
5.7.1 Sanofi Company Profile
5.7.2 Sanofi Nano-drug Product Specification
5.7.3 Sanofi Nano-drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 Eli Lilly
5.8.1 Eli Lilly Company Profile
5.8.2 Eli Lilly Nano-drug Product Specification
5.8.3 Eli Lilly Nano-drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.9 Astrazeneca
5.9.1 Astrazeneca Company Profile
5.9.2 Astrazeneca Nano-drug Product Specification
5.9.3 Astrazeneca Nano-drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.10 Johnson & Johnson
5.10.1 Johnson & Johnson Company Profile
5.10.2 Johnson & Johnson Nano-drug Product Specification
5.10.3 Johnson & Johnson Nano-drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.11 Celgene
5.11.1 Celgene Company Profile
5.11.2 Celgene Nano-drug Product Specification
5.11.3 Celgene Nano-drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.12 Novavax
5.12.1 Novavax Company Profile
5.12.2 Novavax Nano-drug Product Specification
5.12.3 Novavax Nano-drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.13 Stryker
5.13.1 Stryker Company Profile
5.13.2 Stryker Nano-drug Product Specification
5.13.3 Stryker Nano-drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.14 Gilead Sciences
5.14.1 Gilead Sciences Company Profile
5.14.2 Gilead Sciences Nano-drug Product Specification
5.14.3 Gilead Sciences Nano-drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.15 OSI Pharmaceuticals
5.15.1 OSI Pharmaceuticals Company Profile
5.15.2 OSI Pharmaceuticals Nano-drug Product Specification
5.15.3 OSI Pharmaceuticals Nano-drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.16 Kadmon Pharmaceuticals
5.16.1 Kadmon Pharmaceuticals Company Profile
5.16.2 Kadmon Pharmaceuticals Nano-drug Product Specification
5.16.3 Kadmon Pharmaceuticals Nano-drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.17 Samyang Biopharm
5.17.1 Samyang Biopharm Company Profile
5.17.2 Samyang Biopharm Nano-drug Product Specification
5.17.3 Samyang Biopharm Nano-drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.18 Mitsubishi Pharma
5.18.1 Mitsubishi Pharma Company Profile
5.18.2 Mitsubishi Pharma Nano-drug Product Specification
5.18.3 Mitsubishi Pharma Nano-drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.19 Kaken Pharmaceutical
5.19.1 Kaken Pharmaceutical Company Profile
5.19.2 Kaken Pharmaceutical Nano-drug Product Specification
5.19.3 Kaken Pharmaceutical Nano-drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.20 Selecta Biosciences
5.20.1 Selecta Biosciences Company Profile
5.20.2 Selecta Biosciences Nano-drug Product Specification
5.20.3 Selecta Biosciences Nano-drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.21 Par Pharmaceutical
5.21.1 Par Pharmaceutical Company Profile
5.21.2 Par Pharmaceutical Nano-drug Product Specification
5.21.3 Par Pharmaceutical Nano-drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.22 Cerulean Pharma
5.22.1 Cerulean Pharma Company Profile
5.22.2 Cerulean Pharma Nano-drug Product Specification
5.22.3 Cerulean Pharma Nano-drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.23 Navidea Biopharmaceuticals
5.23.1 Navidea Biopharmaceuticals Company Profile
5.23.2 Navidea Biopharmaceuticals Nano-drug Product Specification
5.23.3 Navidea Biopharmaceuticals Nano-drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.24 Lummy
5.24.1 Lummy Company Profile
5.24.2 Lummy Nano-drug Product Specification
5.24.3 Lummy Nano-drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Nano-drug Market Size (2015-2026)
6.2 North America Nano-drug Key Players in North America (2015-2020)
6.3 North America Nano-drug Market Size by Type (2015-2020)
6.4 North America Nano-drug Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Nano-drug Market Size (2015-2026)
7.2 East Asia Nano-drug Key Players in North America (2015-2020)
7.3 East Asia Nano-drug Market Size by Type (2015-2020)
7.4 East Asia Nano-drug Market Size by Application (2015-2020)
8. Europe
8.1 Europe Nano-drug Market Size (2015-2026)
8.2 Europe Nano-drug Key Players in North America (2015-2020)
8.3 Europe Nano-drug Market Size by Type (2015-2020)
8.4 Europe Nano-drug Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Nano-drug Market Size (2015-2026)
9.2 South Asia Nano-drug Key Players in North America (2015-2020)
9.3 South Asia Nano-drug Market Size by Type (2015-2020)
9.4 South Asia Nano-drug Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Nano-drug Market Size (2015-2026)
10.2 Southeast Asia Nano-drug Key Players in North America (2015-2020)
10.3 Southeast Asia Nano-drug Market Size by Type (2015-2020)
10.4 Southeast Asia Nano-drug Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Nano-drug Market Size (2015-2026)
11.2 Middle East Nano-drug Key Players in North America (2015-2020)
11.3 Middle East Nano-drug Market Size by Type (2015-2020)
11.4 Middle East Nano-drug Market Size by Application (2015-2020)
12. Africa
12.1 Africa Nano-drug Market Size (2015-2026)
12.2 Africa Nano-drug Key Players in North America (2015-2020)
12.3 Africa Nano-drug Market Size by Type (2015-2020)
12.4 Africa Nano-drug Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Nano-drug Market Size (2015-2026)
13.2 Oceania Nano-drug Key Players in North America (2015-2020)
13.3 Oceania Nano-drug Market Size by Type (2015-2020)
13.4 Oceania Nano-drug Market Size by Application (2015-2020)
14. South America
14.1 South America Nano-drug Market Size (2015-2026)
14.2 South America Nano-drug Key Players in North America (2015-2020)
14.3 South America Nano-drug Market Size by Type (2015-2020)
14.4 South America Nano-drug Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Nano-drug Market Size (2015-2026)
15.2 Rest of the World Nano-drug Key Players in North America (2015-2020)
15.3 Rest of the World Nano-drug Market Size by Type (2015-2020)
15.4 Rest of the World Nano-drug Market Size by Application (2015-2020)
16 Nano-drug Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter’s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Research Methodology:
Nano-drug Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|